The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antiserum Market 2024 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global Antiserum market size was valued at USD 1326.2 million in 2022 and is forecast to a readjusted size of USD 2067.2 million by 2029 with a CAGR of 6.5% during review period.
Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.
Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.
Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
The Global Info Research report includes an overview of the development of the Antiserum industry chain, the market status of Clinical (Antitoxin Serum, Antibacterial Serum), Laboratory (Antitoxin Serum, Antibacterial Serum), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antiserum.
Regionally, the report analyzes the Antiserum markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antiserum market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antiserum market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antiserum industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Antitoxin Serum, Antibacterial Serum).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antiserum market.
Regional Analysis: The report involves examining the Antiserum market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antiserum market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antiserum:
Company Analysis: Report covers individual Antiserum players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antiserum This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical, Laboratory).
Technology Analysis: Report covers specific technologies relevant to Antiserum. It assesses the current state, advancements, and potential future developments in Antiserum areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antiserum market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antiserum market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others
Market segment by Application
Clinical
Laboratory
Market segment by players, this report covers
BD
Bio-Rad
Shanghai Serum Bio-Technology Co., Ltd.
China National Pharmaceutical Group
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Bharat Serums and Vaccines
SSI Diagnostica
GD Animal Health
MicroPharm
Peptide Institute Inc.
Rare Disease Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antiserum product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antiserum, with revenue, gross margin and global market share of Antiserum from 2018 to 2023.
Chapter 3, the Antiserum competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antiserum market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiserum.
Chapter 13, to describe Antiserum research findings and conclusion.
The global Antiserum market size was valued at USD 1326.2 million in 2022 and is forecast to a readjusted size of USD 2067.2 million by 2029 with a CAGR of 6.5% during review period.
Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.
Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.
Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
The Global Info Research report includes an overview of the development of the Antiserum industry chain, the market status of Clinical (Antitoxin Serum, Antibacterial Serum), Laboratory (Antitoxin Serum, Antibacterial Serum), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antiserum.
Regionally, the report analyzes the Antiserum markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antiserum market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antiserum market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antiserum industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Antitoxin Serum, Antibacterial Serum).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antiserum market.
Regional Analysis: The report involves examining the Antiserum market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antiserum market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antiserum:
Company Analysis: Report covers individual Antiserum players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antiserum This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical, Laboratory).
Technology Analysis: Report covers specific technologies relevant to Antiserum. It assesses the current state, advancements, and potential future developments in Antiserum areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antiserum market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antiserum market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others
Market segment by Application
Clinical
Laboratory
Market segment by players, this report covers
BD
Bio-Rad
Shanghai Serum Bio-Technology Co., Ltd.
China National Pharmaceutical Group
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Bharat Serums and Vaccines
SSI Diagnostica
GD Animal Health
MicroPharm
Peptide Institute Inc.
Rare Disease Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antiserum product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antiserum, with revenue, gross margin and global market share of Antiserum from 2018 to 2023.
Chapter 3, the Antiserum competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antiserum market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiserum.
Chapter 13, to describe Antiserum research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Antiserum
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antiserum by Type
1.3.1 Overview: Global Antiserum Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Antiserum Consumption Value Market Share by Type in 2022
1.3.3 Antitoxin Serum
1.3.4 Antibacterial Serum
1.3.5 Antiviral Serum
1.3.6 Others
1.4 Global Antiserum Market by Application
1.4.1 Overview: Global Antiserum Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clinical
1.4.3 Laboratory
1.5 Global Antiserum Market Size & Forecast
1.6 Global Antiserum Market Size and Forecast by Region
1.6.1 Global Antiserum Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Antiserum Market Size by Region, (2018-2029)
1.6.3 North America Antiserum Market Size and Prospect (2018-2029)
1.6.4 Europe Antiserum Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Antiserum Market Size and Prospect (2018-2029)
1.6.6 South America Antiserum Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Antiserum Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Antiserum Product and Solutions
2.1.4 BD Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BD Recent Developments and Future Plans
2.2 Bio-Rad
2.2.1 Bio-Rad Details
2.2.2 Bio-Rad Major Business
2.2.3 Bio-Rad Antiserum Product and Solutions
2.2.4 Bio-Rad Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Rad Recent Developments and Future Plans
2.3 Shanghai Serum Bio-Technology Co., Ltd.
2.3.1 Shanghai Serum Bio-Technology Co., Ltd. Details
2.3.2 Shanghai Serum Bio-Technology Co., Ltd. Major Business
2.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product and Solutions
2.3.4 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shanghai Serum Bio-Technology Co., Ltd. Recent Developments and Future Plans
2.4 China National Pharmaceutical Group
2.4.1 China National Pharmaceutical Group Details
2.4.2 China National Pharmaceutical Group Major Business
2.4.3 China National Pharmaceutical Group Antiserum Product and Solutions
2.4.4 China National Pharmaceutical Group Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 China National Pharmaceutical Group Recent Developments and Future Plans
2.5 CSL
2.5.1 CSL Details
2.5.2 CSL Major Business
2.5.3 CSL Antiserum Product and Solutions
2.5.4 CSL Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CSL Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Antiserum Product and Solutions
2.6.4 Merck Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck Recent Developments and Future Plans
2.7 BTG
2.7.1 BTG Details
2.7.2 BTG Major Business
2.7.3 BTG Antiserum Product and Solutions
2.7.4 BTG Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 BTG Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Antiserum Product and Solutions
2.8.4 Pfizer Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Haffkine Bio-Pharmaceutical
2.9.1 Haffkine Bio-Pharmaceutical Details
2.9.2 Haffkine Bio-Pharmaceutical Major Business
2.9.3 Haffkine Bio-Pharmaceutical Antiserum Product and Solutions
2.9.4 Haffkine Bio-Pharmaceutical Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Haffkine Bio-Pharmaceutical Recent Developments and Future Plans
2.10 Vins Bioproducts
2.10.1 Vins Bioproducts Details
2.10.2 Vins Bioproducts Major Business
2.10.3 Vins Bioproducts Antiserum Product and Solutions
2.10.4 Vins Bioproducts Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Vins Bioproducts Recent Developments and Future Plans
2.11 Bharat Serums and Vaccines
2.11.1 Bharat Serums and Vaccines Details
2.11.2 Bharat Serums and Vaccines Major Business
2.11.3 Bharat Serums and Vaccines Antiserum Product and Solutions
2.11.4 Bharat Serums and Vaccines Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bharat Serums and Vaccines Recent Developments and Future Plans
2.12 SSI Diagnostica
2.12.1 SSI Diagnostica Details
2.12.2 SSI Diagnostica Major Business
2.12.3 SSI Diagnostica Antiserum Product and Solutions
2.12.4 SSI Diagnostica Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 SSI Diagnostica Recent Developments and Future Plans
2.13 GD Animal Health
2.13.1 GD Animal Health Details
2.13.2 GD Animal Health Major Business
2.13.3 GD Animal Health Antiserum Product and Solutions
2.13.4 GD Animal Health Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 GD Animal Health Recent Developments and Future Plans
2.14 MicroPharm
2.14.1 MicroPharm Details
2.14.2 MicroPharm Major Business
2.14.3 MicroPharm Antiserum Product and Solutions
2.14.4 MicroPharm Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 MicroPharm Recent Developments and Future Plans
2.15 Peptide Institute Inc.
2.15.1 Peptide Institute Inc. Details
2.15.2 Peptide Institute Inc. Major Business
2.15.3 Peptide Institute Inc. Antiserum Product and Solutions
2.15.4 Peptide Institute Inc. Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Peptide Institute Inc. Recent Developments and Future Plans
2.16 Rare Disease Therapeutics
2.16.1 Rare Disease Therapeutics Details
2.16.2 Rare Disease Therapeutics Major Business
2.16.3 Rare Disease Therapeutics Antiserum Product and Solutions
2.16.4 Rare Disease Therapeutics Antiserum Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Rare Disease Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Antiserum Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Antiserum by Company Revenue
3.2.2 Top 3 Antiserum Players Market Share in 2022
3.2.3 Top 6 Antiserum Players Market Share in 2022
3.3 Antiserum Market: Overall Company Footprint Analysis
3.3.1 Antiserum Market: Region Footprint
3.3.2 Antiserum Market: Company Product Type Footprint
3.3.3 Antiserum Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Antiserum Consumption Value and Market Share by Type (2018-2023)
4.2 Global Antiserum Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Antiserum Consumption Value Market Share by Application (2018-2023)
5.2 Global Antiserum Market Forecast by Application (2024-2029)
6 North America
6.1 North America Antiserum Consumption Value by Type (2018-2029)
6.2 North America Antiserum Consumption Value by Application (2018-2029)
6.3 North America Antiserum Market Size by Country
6.3.1 North America Antiserum Consumption Value by Country (2018-2029)
6.3.2 United States Antiserum Market Size and Forecast (2018-2029)
6.3.3 Canada Antiserum Market Size and Forecast (2018-2029)
6.3.4 Mexico Antiserum Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Antiserum Consumption Value by Type (2018-2029)
7.2 Europe Antiserum Consumption Value by Application (2018-2029)
7.3 Europe Antiserum Market Size by Country
7.3.1 Europe Antiserum Consumption Value by Country (2018-2029)
7.3.2 Germany Antiserum Market Size and Forecast (2018-2029)
7.3.3 France Antiserum Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Antiserum Market Size and Forecast (2018-2029)
7.3.5 Russia Antiserum Market Size and Forecast (2018-2029)
7.3.6 Italy Antiserum Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Antiserum Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Antiserum Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Antiserum Market Size by Region
8.3.1 Asia-Pacific Antiserum Consumption Value by Region (2018-2029)
8.3.2 China Antiserum Market Size and Forecast (2018-2029)
8.3.3 Japan Antiserum Market Size and Forecast (2018-2029)
8.3.4 South Korea Antiserum Market Size and Forecast (2018-2029)
8.3.5 India Antiserum Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Antiserum Market Size and Forecast (2018-2029)
8.3.7 Australia Antiserum Market Size and Forecast (2018-2029)
9 South America
9.1 South America Antiserum Consumption Value by Type (2018-2029)
9.2 South America Antiserum Consumption Value by Application (2018-2029)
9.3 South America Antiserum Market Size by Country
9.3.1 South America Antiserum Consumption Value by Country (2018-2029)
9.3.2 Brazil Antiserum Market Size and Forecast (2018-2029)
9.3.3 Argentina Antiserum Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Antiserum Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Antiserum Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Antiserum Market Size by Country
10.3.1 Middle East & Africa Antiserum Consumption Value by Country (2018-2029)
10.3.2 Turkey Antiserum Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Antiserum Market Size and Forecast (2018-2029)
10.3.4 UAE Antiserum Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Antiserum Market Drivers
11.2 Antiserum Market Restraints
11.3 Antiserum Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Antiserum Industry Chain
12.2 Antiserum Upstream Analysis
12.3 Antiserum Midstream Analysis
12.4 Antiserum Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
